Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 9.070

+6.0%

Oct 31 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Swift who wrote (192)	6/26/1999 6:17:00 PM
From: Mike McFarland	Read Replies (1) of 233

Just a quick look on the recap site shows that SmithKline was into that deal for 32.5M--I suppose a person could sort through all the quarterly reports and see just what milestones were met, and how much was spent on the trial... Don't know how long that trial took, impetigo--I was not following magn for a couple years. But it wont take long for an answer to pop up, either here or on the Yahoo thread. If pex fails, expect the burn rate to come down quite a bit, I cant see them launching a whole new trial. And I don't see how the FDA is going to ask for "better control". Maybe I am dense, but if the stuff is as good as oral antibiotics, I think you have to add it to the arsenal. Everything that I heard on the vcall sounded positive, hope I have not deluded myself. Have you listened to the vcall tape?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next